MedTrace Logo

AIR (Artificial Implant to Restore the Medial Meniscus Function)2 Clinical Investigation

NCT05297175 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-03-28

No results posted yet for this study

Summary

The AIR2 Study is a multi-center, prospective, interventional clinical trial with the objective to evaluate the safety and performance of the Trammpolin® medial meniscus prosthesis.

Conditions

  • Knee Injuries and Disorders

Interventions

DEVICE

Trammpolin medial meniscus prosthesis

Implantation of the Trammpolin medial meniscus prosthesis in patients with a severe medial meniscus damage

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • ATRO Medical B.V.

    lead INDUSTRY

Principal Investigators

  • T. van Tienen, MD. PhD. · Sponsor GmbH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-19
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05297175 on ClinicalTrials.gov